Genetic and Immunological Backgrounds in Advanced NSCLC Patients Treated with Immunotherapy - NGS and Flow Cytometry Analysis

被引：0
|
作者：
Krzyzanowska, N. [1 ]
Nicos, M. [1 ]
Wojas-Krawczyk, K. [1 ]
Krawczyk, P. [1 ]
Chmielewska, I. [1 ]
Jankowski, T. [1 ]
Kucharczyk, T. [1 ]
Wojcik-Superczynska, M. [1 ]
Sroka-Bartnicka, A. [1 ]
Stokowy, T. [2 ]
Milanowski, J. [1 ]
机构：
[1] Med Univ Lublin, Lublin, Poland
[2] Univ Bergen, Bergen, Norway
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06E.04
引用
收藏
页码：S330 / S331
页数：2
相关论文
共 50 条
  • [41] Prognostic Value of FDG-PET Metrics for Advanced NSCLC Patients Treated with First-line Immunotherapy
    Andraos, T. Y.
    Halmos, B.
    Cheng, H.
    Huntzinger, C.
    Ohri, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E116 - E117
  • [42] Baseline Tumor Size and Survival Outcomes among Patients with Advanced NSCLC treated with First-Line Immunotherapy
    Uehara, Y.
    Hakozaki, T.
    Kitadai, R.
    Hosomi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S392 - S392
  • [43] Relationship Between Buccal Microbiome Diversity and Overall Survival in Locally Advanced NSCLC Patients Treated with Chemoradiation and Immunotherapy
    Augustyn, A.
    Fang, P., Sr.
    He, J.
    Qiao, Y.
    Lee, P.
    Koong, A. C.
    Heymach, J.
    Tsao, A.
    Petrosino, J.
    Lin, S. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S109 - S109
  • [44] Does Disease Burden on PET Predict Outcomes for Advanced NSCLC Patients Treated With First-Line Immunotherapy?
    Andraos, T. Y.
    Halmos, B.
    Cheng, H.
    Huntzinger, C.
    Shirvani, S.
    Ohri, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E428 - E428
  • [45] Real-World Treatment Patterns and Outcomes in Patients With Advanced NSCLC Treated After Prior Chemotherapy and Immunotherapy
    Haggstrom, D.
    Mhatre, S. K.
    Chen, F.
    Gao, R.
    Carroll, C.
    Patel, R.
    Park, J.
    Descoteaux, A.
    Stokes, M.
    Daniel, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S409 - S409
  • [46] Body Mass Index over Time is Associated with Overall Survival in Advanced NSCLC Patients Treated with Immunotherapy.
    Labomascus, S.
    Fughhi, I.
    Bonomi, P.
    Mcdonald, A.
    Batus, M.
    Fidler, M. J.
    Basu, S.
    Borgia, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S688 - S688
  • [47] Benefit of immunotherapy in advanced NSCLC patients selected by KRAS mutations: A single institute retrospective analysis
    Soto Castillo, J. J.
    Corral de la Fuente, E.
    Olmedo Garcia, M. E.
    Gomez Rueda, A.
    Lage, Y.
    Vida Navas, E. M.
    Sanz Gomez, L.
    Lario, M.
    Garrido Lopez, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S765 - S766
  • [48] Prospect of immunotherapy alone in patients with advanced NSCLC with high btmb: a review and a meta-analysis
    Feiyu Zhao
    Xiaochen Qiu
    Qinna Yang
    Shuyue Gao
    Fan Yang
    Niansong Qian
    Holistic Integrative Oncology, 2 (1):
  • [49] Molecular profiling by NGS upon progression disease in advanced stage NSCLC patients.
    Serna, Roberto
    Sanchez, Alfredo
    De Julian, Maria
    Giron, Carlos Garcia
    Domine, Manuel
    Blasco, Ana
    Torres, Jose Miguel Sanchez
    Oramas, Juana
    Bosch-Barrera, Joaquim
    Sala, Maria Angeles
    Sereno, Maria
    Ortega, Ana Laura
    Velarde, Luis Enrique Chara
    Hernandez, Berta
    Padilla, Airam
    Coves, Juan
    Lewintre, Eloisa Jantus
    Molina-Vila, Miguel Angel
    Romero, Atocha
    Provencio-Pulla, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Concurrent DNA and RNA NGS Testing to Characterize Rare Fusions in Advanced NSCLC Patients
    Feliciano, J. L.
    Gai, L.
    Rivers, Z.
    Hockenberry, A. J.
    Nimeiri, H.
    Beauchamp, K. A.
    Ben-Shachar, R.
    Guinney, J.
    Patel, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S510 - S511
12345